Abstract
C3H and C57 BL/6 mice carrying methylcholanthrene-induced fibrosarcomas were injected i.p. daily with histamine, metiamide (anti-histamine type-2 receptor), histamine + metiamide, mepyramine (anti-histamine type-1 receptor), serotonin and methysergide (anti-serotonin). Inhibition of tumour growth and lengthened survival were observed with histamine and histamine + metiamide. The best results (both on tumour growth and survival) were obtained with serotonin. Survival was increased by metiamide and decreased by mepyramine and methysergide. In histamine-treated and in serotonin-treated mice, histological studies of the tumours showed large and numerous foci of haemorrhagic necrosis. Stimulation of histamine type-1 or serotonin receptors and inhibition of histamine type-2 receptors play a beneficial role in the host's defence against tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Burtin, C., Scheinmann, P., Salomon, J. et al. Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: Influence of H1 and H2 histamine receptors. Br J Cancer 45, 54–60 (1982). https://doi.org/10.1038/bjc.1982.7
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.7
This article is cited by
-
Antitumor properties of histamine in vivo
Nature Medicine (2011)
-
Reply to Antitumor properties of histamine in vivo
Nature Medicine (2011)
-
Alleviating oxidative stress in cancer immunotherapy: a role for histamine?
Medical Oncology (2000)
-
Growth, microvessel density and tumor cell invasion of human colon adenocarcinoma under repeated treatment with hyperthermia and serotonin
Journal of Cancer Research and Clinical Oncology (1995)
-
Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus
Cancer Immunology Immunotherapy (1991)